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ABSTRACT

Fear of cancer recurrence (FCR) is regarded as one of the most common and distressing issues
affecting cancer survivors. Observational studies have identified several modifiable
characteristics associated with FCR. However, many of the findings are based on post-hoc
analyses and come from studies in which FCR was not identified as a primary outcome. This
study sought to overcome these limitations by using a model comprised of cognitive, behavioral,
and social characteristics as a framework for examining modifiable characteristics associated
with FCR. A sample of 120 patients who had been diagnosed with colorectal cancer and
completed cancer treatment in the past 6 to 36 months was recruited during routine outpatient
visits or by mail for participation in the study. Medical record reviews were conducted to assess
clinical variables, and participants filled out a standard demographic questionnaire as well as
self-report measures of characteristics resistant to modification (perceived risk of recurrence,
neuroticism, conscientiousness), cognitive modifiable characteristics (self-efficacy, positive
beliefs about worry, negative beliefs about worry, misinterpretation of symptoms, intolerance of
uncertainty and rumination), behavioral modifiable characteristics (reassurance seeking and
health-related reassurance seeking), and social modifiable characteristics (social support and
social constraints). As hypothesized, results demonstrated that modifiable characteristics (i.e.,
self efficacy, positive beliefs about worry, negative beliefs about worry, intolerance of
uncertainty, rumination, reassurance seeking, health-related reassurance seeking and social
constraints) were associated with FCR (all p’s < .05). Multivariable regression analyses
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demonstrated that modifiable characteristics accounted for 13% of the variance in FCR beyond
that accounted for by non-modifiable characteristics (p < .001), with self-efficacy, rumination
and health-related reassurance seeking accounting for unique variance in FCR. This study has
identified several modifiable characteristics that should be considered as targets for interventions
seeking to reduce FCR among cancer survivors.

v

INTRODUCTION

Fear of cancer recurrence (FCR) is regarded as one of the most common and distressing
issues affecting cancer survivors (Vickberg, 2003). Studies conducted among patients with
breast, ovarian, colon, lung or prostate cancer demonstrate that FCR is among the top concerns
for these survivors (Baker, Denniston, Smith & West, 2005; Fitch, Gray & Franssen, 2000;
Mehnert, Berg, Henrich & Herschbach, 2009). Furthermore, greater FCR has been associated
with greater psychological distress, more depressive symptoms, greater anxiety, and poorer
quality of life (Clayton, Mishel & Belyea, 2006; Skaali et al., 2009; Thewes et al., 2012).
Additionally, patients with greater FCR tend to use more healthcare services, which likely results
in greater costs to the healthcare system (Lebel, Tomei, Feldstain, Beattie & McCallum, 2013).
Studies have identified a number of characteristics associated with fear of recurrence. As
described below, these characteristics can be divided up into characteristics that are generally
resistant to modification (e.g., demographic, clinical, and personality characteristics of the
individual), which will be referred to as “non-modifiable” characteristics, and modifiable
characteristics (e.g., psychological characteristics of the individual). It is important to distinguish
between those characteristics that are modifiable versus those that are not so that effective
interventions can be developed to target the modifiable characteristics associated with FCR. The
purpose of this study is to identify modifiable characteristics associated with FCR in order to
inform future development of an intervention.
Systematic reviews of the literature on FCR have identified a number of non-modifiable
characteristics related to this construct (Crist & Grunfeld, 2013; Koch, Jansen, Brenner & Arndt,
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2013; Simard et al., 2013). These reviews have reported that greater FCR is consistently
associated with younger age, worse disease severity, and more intense treatment (Simard et al.,
2013). For example, a recent study by McGinty and colleagues (2012) found that breast cancer
survivors who were younger, at a more advanced disease stage and reported greater perceived
risk of recurrence reported greater FCR. Another study of patients with mixed cancer diagnoses
found that greater fear of recurrence was associated with more advanced cancer and
administration of adjuvant chemotherapy (Savard & Ivers, 2013). These findings regarding nonmodifiable risk characteristics can help clinicians identify those patients who might be most in
need of an intervention designed to prevent or relieve FCR. However, to determine what
characteristics should be targeted in such interventions, it is important to identify modifiable
characteristics associated with FCR.
With regard to modifiable characteristics, two pertinent lines of research will be
reviewed: 1) observational studies examining characteristics associated with FCR, and 2)
intervention studies on FCR. A useful conceptual framework for categorizing and distinguishing
these modifiable characteristics are cognitive behavioral models of health anxiety and
generalized anxiety disorder (Dugas, Gagnon, Ladouceur & Freeston, 1998; Dugas, Marchand,
Ladouceur, 2005; Langlois,& Ladouceur, 2004). These models focus on the impact that thoughts
and behaviors can have on emotional reactions, like FCR. For example, individuals with
heightened FCR may be more likely to experience biased cognitions such as misinterpreting
benign physical symptoms and engage in reassurance seeking behaviors, such as visits to the
doctor. Social characteristics, such as the availability of social support and a lack of social
constraints in important relationships, have also been shown to be particularly important for
successful emotional adjustment to cancer (Lepore, 2001; Lepore & Revenson, 2007). Therefore,
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the cognitive behavioral model will be expanded upon in this study to include social
characteristics as well. With this conceptual framework in mind, we review relevant
observational and interventional research to identify cognitive, behavioral and social
characteristics that may be related to FCR.
Observational studies have identified a number of modifiable characteristics associated
with FCR. In one systematic review of these studies, researchers found that social influences,
such as family stressors and having fewer significant others were related to greater FCR (Crist &
Grunfeld, 2013). Other studies have identified behaviors associated with FCR, such as frequent
visits to the doctors (Lebel et al., 2013; Koch et al., 2014). Additionally, a number of cognitive
characteristics have also been found to be related to FCR. Having more intrusive thoughts,
misinterpreting benign physical symptoms, engaging in negative thinking styles, making greater
use of avoidance coping strategies, using fewer positive reappraisals, and having lower selfefficacy are all associated with higher reported fear of recurrence. (Melchior et al., 2013; Myers
et al., 2013; Park, Cho, Blank, & Wortmann, 2013; Thewes, Bell & Butow, 2013).
These studies help identify intervention targets worthy of study, such as coping strategies,
misinterpretation of physical symptoms, reassurance seeking, intrusive thoughts, negative
thinking styles, the use of cognitive reappraisals, and self-efficacy. However, the studies that
produced these findings are characterized by a number of limitations. Many of the findings are
based on post-hoc analyses and many come from studies in which FCR was not identified as a
primary outcome; consequently, these studies were not specifically designed to assess
characteristics associated with FCR, nor were their analyses based on a theoretical or conceptual
model of FCR. Additionally, many of the studies were conducted with only breast cancer
patients (Melchior et al., 2013; Thewes, Bell & Butow, 2013). Consequently, the generalizability
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of these findings to survivors of other types of cancer and possible gender differences in FCR are
unknown.
The second line of research pertinent to this topic is the intervention literature on FCR.
To date, only eight studies have been conducted that were designed specifically to test
interventions for FCR. Two studies evaluated a manualized cognitive-existential intervention for
FCR. One of these studies by Lebel and colleagues (2014) used a single-arm design to evaluate a
cognitive-existential group intervention for FCR among 56 women with breast or ovarian cancer
who reported moderate to high levels of FCR. The other study, by Moran and colleagues (2017),
used a subset of cancer survivors participating in a larger randomized controlled trial evaluating
the efficacy of a manualized cognitive-existential intervention to assess one aspect of the
intervention, the worst case scenario exercise, which was adapted to an individual format. In the
worst case scenario exercise, participants were asked to write their worst case scenario, then read
it out-loud every day and rate their anxiety before and after (Moran et al., 2017). One of the
strengths of these studies is that they used a manualized intervention with content based upon
two existing theoretical frameworks (Lebel et al., 2014). Specifically, the interventions draw on
Leventhal’s common sense model (Leventhal, Leventhal & Richard, 1998), which can be used to
posit that FCR results when internal and external cues (e.g., physical symptoms or medical
appointments) increase perceived risk of recurrence. Increases in perceived risk of recurrence
then lead to even more focus on physical symptoms and misinterpretations of them as signs of
disease recurrence, which, in turn, can lead to maladaptive behaviors such as reassurance
seeking, excessive worry, avoidance, and body checking (Lebel et al., 2014). Therefore, these
interventions sought to increase awareness of triggers of FCR, decrease maladaptive coping
strategies and increase adaptive coping strategies. The interventions also draw on Mishel’s
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uncertainty in illness theory (Mishel, 1988), which can be used to posit that FCR is heightened
when individuals are uncertain about the outcome of their illness due to treatment complexity or
lack of knowledge about which physical symptoms might indicate a recurrence. Therefore, these
interventions aimed to increase knowledge regarding symptoms of recurrence and increase
tolerance of uncertainty. Additionally, cognitive models of worry emphasize the function of
worry as a strategy for avoiding feared outcomes, such as disease recurrence, by interfering with
emotional processing (Furer, Walker & Freeston, 2001; Ladouceur et al., 2000; Langlois &
Ladouceur, 2004). To this end, the interventions targeted awareness of FCR, catastrophic
thoughts about physical symptoms, maladaptive coping strategies, avoidance of feared outcomes,
beliefs about the benefits of worrying and toleration of uncertainty (Lebel et al., 2014). Authors
of the first study reported significant improvements on measures of FCR, cancer-specific distress
and uncertainty (Lebel et al., 2014). However, the study lacked a control group and did not
examine mediators, limiting the conclusions that can be drawn from the findings. The second
study by Moran and colleagues (2017) found that higher adherence to the worst case scenario
homework was significantly related to lower post-intervention FCR. However, this study was
comprised of a subset of sample participants (53% of the overall sample) who agreed to share
their homework, lacked a control group and could not isolate the effects of the exercises from the
overall therapy effects (Moran et al., 2017).
Two studies to date have examined the efficacy of cognitive behavioral therapy for FCR.
One of these studies by Herschbach and colleagues (2010), randomly assigned 174 cancer
patients to either cognitive behavioral group therapy (CBT) or a supportive-experiential group
therapy (SET), and compared them to a control group recruited one year later. Both interventions
involved four 90-minutes group sessions. Although a theoretical framework was not identified,
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the CBT intervention was based on principles of CBT and therefore targeted awareness of fears
and triggers for FCR, coping strategies and the ability to withstand their fears regarding
recurrence (Herschbach et al., 2010). The SET intervention was client-centered and nondirective, targeting emotional and social support, but allowing patients to choose topics of
discussion (e.g., coping with illness, partnership and social support; Herschbach et al., 2010).
Findings showed that fear of progression decreased in both intervention groups as compared to
the control group (Hershbach et al., 2010). However, participants in the control group were not
randomized and were recruited at a later time, and mediators were not examined to identify
effective intervention targets. The other study by van de Wal and colleagues (2017) used a
randomized controlled trial to evaluate the efficacy of an individual cognitive behavioral
intervention among 88 breast, prostate or colorectal cancer survivors with high FCR. One of the
strengths of this study is that it used one existing theoretical framework to inform the
intervention content (van de Wal et al., 2017). Similar to the study by Lebel and colleagues
(2014), the intervention draws on the theory proposed by Lee-Jones and colleagues (1997)
derived from Leventhal’s common sense model (Leventhal, Leventhal & Richard, 1998).
Therefore, this intervention sought to increase awareness of thoughts, behaviors and emotions
related to FCR, decrease maladaptive thinking patterns and beliefs about FCR, and increase
adaptive behavioral responses (van de Wal et al., 2015). The intervention was delivered during
five face-to-face sessions and three brief online chat or telephone sessions. When compared to
the usual care group, patients who received the CBT intervention reported significantly less FCR
and exhibited greater clinically significant improvement in FCR (van de Wal et al., 2017).
However, the study did not examine mediators nor did it include an active control group, again
limiting the conclusions that can be drawn from the findings.
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A single-arm study evaluated a Mindfulness-based Cognitive Therapy (MBCT) group
intervention for 19 men with advanced prostate cancer (Chambers, Foley, Galt, Ferguson, &
Clutton, 2012). The intervention addressed the following targets in eight weekly two-hour group
sessions: intrusive negative thoughts, existential regret, increased hyperarousal and anxiety,
experiential avoidance, the extent to which treatment side effects were experienced as
bothersome and illness adjustment (Chambers et al., 2012). The authors reported significant
improvements on measures of anxiety, avoidance and mindfulness. Additionally, there was a
non-significant trend for improvement on a measure of FCR (Chambers et al., 2012). However,
this study included only a single arm, so it is unclear whether the improvements occurred as a
result of the intervention or due to extraneous factors. Additionally, the investigators did not test
for mediators, so no conclusions can be drawn about which intervention targets might be
responsible for changes associated with intervention delivery.
A study by Dieng and colleagues (2016) evaluated a psychoeducational intervention for
melanoma cancer survivors in which participants were randomly assigned to the intervention
comprised of an educational booklet and three individual telephone-based therapy sessions or
usual care (Dieng et al., 2016). Development of the educational booklet and the therapy sessions
were based on the Transactional Model of Stress and Coping and core principles of brief
psychodynamically-oriented psychotherapy. The overall goals of the intervention were to
understand the participant using empathic listening and to facilitate development of effective
emotional and behavioral coping skills (Dieng et al., 2015). Beneficial effects were found for the
intervention group on FCR, stress and melanoma-related knowledge (Dieng et al., 2016).
However, limited conclusions can be drawn regarding the active ingredient in the treatment
because the study did not examine mediators, nor did it have an active control group.
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A study examining the effectiveness of a gratitude intervention on death-related FCR
included 67 breast cancer survivors randomly assigned to a 6-week online gratitude intervention
or a 6-week online control condition (Otto, Szczesny, Woriano, Laurenceau & Siegel, 2016). All
participants were asked to spend 10 minutes writing, with those in the intervention group being
prompted to write a letter expressing gratitude and those in the control group being prompted to
list and describe activities they had engaged in recently (Otto, et al., 2016). The intervention was
hypothesized to exert an influence on FCR through increases in positive affect and weekly goal
pursuit, which were included as mediators in the analyses (Otto et al., 2016). Several models
were cited as informing the intervention’s proposed mechanisms of change including
Fredrickson’s broaden-and-build theory of positive emotions, terror management theory and
meaning management theory (Otto et al., 2016). Findings demonstrated beneficial effects on
death worry which was mediated by meaningful goal pursuit, but no significant changes in FCR
were found (Otto et al., 2016). Although this study included an active control group and
examined mediators, it did not find significant effects on overall FCR.
A more recent study by Lichtenthal and colleagues (2017) examined the efficacy of a
computerized cognitive bias modification intervention named the Attention and Interpretation
Modification for Fear of Breast Cancer Recurrence (AIM-FBCR). The AIM-FBCR was based on
cognitive models of anxiety which posit that cognitive biases, including attention to threatrelevant stimuli and interpreting uncertainty in a threatening manner, are involved in the
development and maintenance of anxiety (Lichtenthal et al., 2017). One-hundred and ten breast
cancer survivors were randomly assigned to complete the AIM-FBCR intervention, which
involved completion of an attention modification task and an interpretation modification task, or
a control condition, which involved completion of a similar task without providing reinforcement
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aimed at modifying attention or interpretation of stimuli (Lichtenthal et al., 2017). Beneficial
effects were found for interpretation cognitive biases and health worries, but not overall FCR
(Lichtenthal et al., 2017). However, interpretation of results is limited because the study did not
test for mediation.
Results of these studies are promising, but there are several limitations. Only two of the
studies had an appropriate control group and neither of the studies with active control groups
demonstrated beneficial effects on overall FCR. In addition, only one of these studies conducted
mediational analyses to evaluate whether or not intervention components changed intended
targets, and thereby contributed to improvements in FCR. However, these studies do help
identify intervention targets worthy of study, such as intrusive worry, maladaptive thoughts
about physical symptoms, maladaptive coping strategies (such as excessive reassurance seeking),
beliefs about the benefits of worry, toleration of uncertainty, and social support.
To summarize with regard to non-modifiable characteristics (including ones that are
generally resistant to modification), potential contributors to FCR include age, disease severity,
treatment intensity, perceived risk of recurrence and personality characteristics. Interventions
targeting perceived risk have been largely unsuccessful in altering risk perceptions (Lipkus et al.,
2004; Robb, Campbell, Evans, Miles & Wardle, 2008). Two personality traits, neuroticism and
conscientiousness will be included as non-modifiable characteristics. Personality traits persist
across situations and time, and are generally not considered modifiable. Neuroticism has been
associated with fear of cancer recurrence, as well as other mental health problems (Lahey, 2009).
Additionally, conscientiousness has been associated with compulsive checking and generalized
anxiety disorder (Rosellini & Brown, 2011; Sher, Rossy & Bishop, 2000). Therefore, this study
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examined the following non-modifiable characteristics for their relationship with FCR:
neuroticism, conscientiousness, perceived risk of recurrence, age, and disease severity.
To summarize with regard to cognitive characteristics, those identified as contributors or
potential contributors to FCR in the literature include misinterpretation of physical symptoms,
beliefs about the benefit of worry, toleration of uncertainty, negative thinking styles (e.g.,
rumination), the use of avoidance coping strategies, using fewer positive reappraisals, and lower
self-efficacy. In addition, research evaluating cognitive behavioral models of generalized anxiety
disorder and health anxiety has identified intolerance of uncertainty, misinterpretation of
symptoms, and beliefs about the benefit of worry as key characteristics contributing to intrusive
worry and subsequent anxiety (Dugas et al., 1998; Dugas, Marchand, Ladouceur, 2005;
Langlois,& Ladouceur, 2004). Research among cancer patients has also found that intolerance of
uncertainty is related to psychological distress (Eisenberg et al., 2014; Kurita, Garon, Stanton &
Meyerowitz, 2013), and that the misinterpretation of benign symptoms is a key contributor to
FCR (Mehnert, Berg, Henrich & Herschbach, 2009; Lee-Jones, Humphris, Dixon & Hatcher,
1997). Therefore, this study examined the following cognitive characteristics for their
relationship with FCR: self-efficacy for preventing a cancer recurrence, positive beliefs about the
benefits of worry, negative beliefs about the danger and uncontrollability of worry,
misinterpretation of symptoms, intolerance of uncertainty, and rumination.
To summarize with regard to behavioral characteristics, the literature on behaviors
associated with FCR points to the importance of reassurance seeking behaviors in contributing to
greater FCR. Additionally, intervention studies targeting reassurance seeking have demonstrated
reductions in FCR (Lebel et al., 2014). Cognitive behavioral models of health anxiety also
emphasize the importance of health-related reassurance seeking behaviors, such as visiting the

10

doctor, in maintaining health anxiety (Furer, Walker & Freeston, 2001; Langlois & Ladouceur,
2004). Furthermore, studies on FCR have found that survivors with greater FCR visit the doctor
more frequently (Lebel, 2013; Koch, 2014). Therefore, health-related reassurance seeking
behaviors were examined in the current study for their relationship with FCR. Additionally,
threat-related reassurance seeking behaviors were assessed to determine whether FCR is related
to the tendency to engage in reassurance seeking specific to health or occurs more generally to
the tendency to engage in reassurance seeking in response to any type of threat.
To summarize with regard to social characteristics, observational studies demonstrate that
social influences, such as family stressors and having fewer significant others are associated with
FCR (Crist & Grunfeld, 2013). In addition, an intervention that targeted social support led to
reduced FCR (Hershbach et al., 2010). Furthermore, a large body of literature on psychological
distress in cancer patients has shown that the availability of social support and a lack of social
constraints in important relationships are important for successful emotional adjustment to
cancer (Lepore, 2001). Therefore, social support and social constraints were examined in this
study for their relationship with FCR.
In conclusion, this study used a model comprised of cognitive, behavioral, and social
characteristics as a framework for examining modifiable characteristics associated with FCR.
This is consistent with research on cognitive behavioral models of health anxiety and generalized
anxiety disorder, as well as the literature on FCR. The focus was on survivors of colorectal
cancer who had completed treatment in the past 6 to 36 months. This patient population was
selected for several reasons. First, colorectal cancer is the third most common cancer and third
leading cause of cancer mortality in the U.S. (Siegel, DeSantis & Jemal, 2014). Second, studies
show that FCR is a common and distressing concern among colorectal cancer survivors (Simard
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& Savard, 2009; Taylor, Richardson, Cowley, 2011). Third, an advantage of studying colorectal
cancer survivors is that it affects both males and females, so both genders will be represented in
the study.

Aims of the Current Study
The overall aim of the current study was to identify modifiable characteristics associated
with FCR in order to inform the future creation of an intervention for cancer survivors
experiencing clinically meaningful FCR. Additionally, the study sought to evaluate the relative
contributions of modifiable and non-modifiable characteristics to FCR.

Aim 1
To characterize non-modifiable characteristics associated with FCR.
Hypothesis Set 1. It was hypothesized that greater FCR would be associated with greater
neuroticism, greater conscientiousness, greater perceived risk, younger age and worse disease
severity.

Aim 2
To identify modifiable behavioral, cognitive and social characteristics associated with
FCR.
Hypothesis Set 2. It was hypothesized that greater FCR would be associated with less
self-efficacy for preventing a cancer recurrence, more positive beliefs about worry, more
12

negative beliefs about worry, more misinterpretation of symptoms, less tolerance of uncertainty
and more rumination (cognitive characteristics).
Hypothesis Set 3. It was hypothesized that greater FCR would be associated with more
frequent threat-related and health-related reassurance seeking (behavioral characteristics).
Hypothesis Set 4. It was hypothesized that greater FCR would be associated with less
social support and greater social constraints (social characteristics).

Aim 3
To determine the relative contributions of behavioral, cognitive, and social characteristics
to FCR after accounting for non-modifiable characteristics (i.e., demographic, clinical, and
personality characteristics). Toward this end, the study examined whether or not modifiable
characteristics account for variance in FCR above and beyond that accounted for by nonmodifiable characteristics, and if so, what distinct contributions each modifiable factor makes to
the variance explained
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METHODS

Participants
Participants were patients who met the following eligibility criteria: 1) diagnosed with
stage I-III colorectal cancer, 2) completed treatment for colorectal cancer in the past 6-36
months, 3) no clinical evidence of disease at the time of recruitment, 4) no history of cancer
recurrence 5) not diagnosed with any other form of cancer except non-melanoma skin cancer, 6)
able to read and speak English, 7) 18 years of age or older, and 8) able to provide informed
consent. In order to ensure adequate representation of males and females, patients were recruited
such that at least 40% of the sample would be either male or female.

Procedure
After a review of medical records for initial screening, potentially eligible patients were
approached during a scheduled follow-up visit in the Moffitt Cancer Center Gastrointestinal
Oncology Clinic to have the study protocol explained. If eligible and interested, participants
were asked to sign an IRB-approved informed consent form. They were then given the option of
filling out the study measures during their outpatient visit, taking them home and returning the
completed measures in a self-addressed stamped envelope, or completing the measures at home
via a secure web-based survey. Patients identified as eligible but not scheduled to come in for a
follow-up appointment within the next three months were contacted by phone or e-mail to
determine if they were eligible and interested in participating in the study. Those who expressed
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interest were mailed a packet containing an IRB-approved informed consent form, a study
questionnaire, and a postage paid return envelope. If patients preferred to complete the study
online, instructions for accessing a secure web-based survey were e-mailed to them for
completion.

Measures
Measures of Non-Modifiable Characteristics
Demographic characteristics. The following demographic characteristics were assessed
using a standardized self-report form: age, gender, race, ethnicity, marital status, income,
employment status, number of minor children, and education.
Clinical characteristics. The following clinical characteristics were assessed by
conducting a medical chart review: cancer site, cancer stage at diagnosis, date of diagnosis,
date(s) of treatment(s), and type(s) of treatment(s), date(s) of cancer surveillance tests,
genetic/inherited risk factors.
Perceived Risk. Perceived risk of cancer recurrence was assessed using participants’
estimates of their absolute and comparative risk with items adapted from prior research
(Valdimarsdottir et al., 1995). To assess absolute risk participants were asked, “How likely do
you think you are to have colorectal cancer again during your lifetime?” To assess comparative
risk participants were asked, “What do you think your chances are of having colorectal cancer
again in your lifetime compared to other individuals your age with colorectal cancer who
received the same treatment for the same type of colorectal cancer? The absolute risk item was
rated on a six-point response scale from 1 = extremely unlikely to 6 = extremely likely, and the
15

comparative risk item was rated on a five-point scale from 1 = much higher to 5 = much lower.
Absolute and comparative risk scores were converted to the same metric and then summed to
create a total perceived risk score. This measure has demonstrated adequate internal
consistency with a Cronbach’s alpha of 0.79 (McGinty, Goldenberg & Jacobsen, 2012). In the
present study, this measure demonstrated marginal internal consistency reliability (α = .65),
which is not inconsistent with its length.
Neuroticism. Neuroticism was assessed using the neuroticism subscale of the NEO
Five- Factor Inventory-3 (NEO-FFI-3; McCrae & Costa, 2004). The neuroticism subscale is
comprised of 12 items that are rated on a five-point response scale ranging from 0 = strong
disagreement to 4 = strong agreement. The NEO-FFI-3 has demonstrated good convergent
validity with other validated measures of pathological worry and trait anxiety and adequate
internal consistency reliability, with a Cronbach’s alpha ranging from 0.82 to 0.88 (McCrae &
Costa, 2004). In the present study, this subscale demonstrated adequate internal consistency
reliability (α = .88).
Conscientiousness. Conscientiousness was assessed using the conscientiousness
subscale of the NEO-FFI-3 (McCrae & Costa, 2004). The conscientiousness subscale is
comprised of 12 items that are rated on a five-point response scale ranging from 0 = strong
disagreement to 4 = strong agreement. The NEO-FFI-3 has demonstrated good convergent
validity with other validated measures of pathological worry and trait anxiety and adequate
internal consistency reliability, with a Cronbach’s alpha ranging from 0.79 to 0.87 (McCrae &
Costa, 2004). In the present study, this subscale demonstrated adequate internal consistency
reliability (α = .87).
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Measures of Cognitive Characteristics
Self-Efficacy. Self-efficacy for preventing a cancer recurrence was assessed using one
item adapted from prior research (Clark & Dodge, 1999). Participants were asked, “How
confident are you that you can do things to prevent a cancer recurrence?” This item was rated on
a ten-point scale from 1 = not at all confident to 10 = very confident.
Positive Beliefs about Worry. Positive beliefs about worry was assessed using the
positive beliefs about worry subscale of the 30-item Metacognitions Questionnaire (MCQ-30;
Wells & Cartwright-Hatton, 2004). The positive beliefs subscale is comprised of six items that
are rated on a four-point response scale ranging from 1 = do not agree to 4 = agree very much.
The positive beliefs subscale has demonstrated good convergent validity with other validated
measures of pathological worry and trait anxiety and adequate internal consistency reliability,
with a Cronbach’s alpha of 0.92 (Wells & Cartwright-Hatton, 2004). In the present study, this
subscale demonstrated adequate internal consistency reliability (α = .91).
Negative Beliefs about Worry. Negative beliefs about worry was assessed using the
negative beliefs about the danger and uncontrollability of worry subscale of the 30-item
Metacognitions Questionnaire (MCQ-30; Wells & Cartwright-Hatton, 2004). This subscale is
comprised of six items that are rated on a four-point response scale ranging from 1 = do not
agree to 4 = agree very much. The negative beliefs subscale has demonstrated good convergent
validity with other validated measures of pathological worry and trait anxiety and adequate
internal consistency reliability, with a Cronbach’s alpha of 0.89 (Wells & Cartwright-Hatton,
2004). In the present study, this subscale demonstrated adequate internal consistency reliability
(α = .87).
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Misinterpretation of Symptoms. Misinterpretation of bodily symptoms was assessed
using the Multidimensional Inventory of Hypochondriacal Traits (MIHT) hypochondriacal
absorption subscale (Longley, Watson & Noyes, 2005). The nine-item MIHT hypochondriacal
absorption subscale asks respondents to rate items on a five-point scale ranging from 1 =
strongly disagree/definitely false to 5 = strongly agree/definitely true. The subscale has
demonstrated good concurrent validity with validated measures of hypochondriacal cognitions,
and adequate internal consistency reliability, with Cronbach’s alpha ranging from 0.81 to 0.86
(Longley, Watson & Noyes, 2005). In the present study, this subscale demonstrated adequate
internal consistency reliability (α = .87).
Intolerance of Uncertainty. Intolerance of uncertainty was assessed using the 27-item
Intolerance of Uncertainty Scale (IUS; Buhr & Dugas, 2002). Items are rated on a five-point
scale ranging from 1 = not at all characteristic of me to 5 = entirely characteristic of me. The
IUS has demonstrated good convergent validity with validated measures of worry, depression,
and anxiety, and adequate internal consistency reliability, with a Cronbach’s alpha of 0.94 (Buhr
& Dugas, 2002). In the present study, this measure demonstrated adequate internal consistency
reliability (α = .95).
Rumination. Rumination was assessed using the Rumination-Reflection Questionnaire
(RRQ) rumination subscale (Trapnell & Campbell, 1999). The 12-item rumination subscale asks
participants to indicate their level of agreement or disagreement with items on a five-point
response scale ranging from 1 = strongly disagree to 5 = strongly agree. The rumination
subscale has demonstrated good convergent validity with validated measures of neuroticism and
depression, and adequate internal consistency reliability, with Cronbach’s alpha ranging from
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0.88 to 0.90 (Siegle, Moore & Thase, 2004; Trapnell & Campbell, 1999). In the present study,
this measure demonstrated adequate internal consistency reliability (α = .91).

Measures of Behavioral Characteristics
Threat-related Reassurance Seeking. Reassurance seeking behavior was assessed using
the Threat-related Reassurance Seeking Scale (TRSS). The TRSS is an eight-item measure that
asks about an individual’s tendency to engage in reassurance seeking behaviors (Cougle et al.,
2012). Respondents rate each item on a seven-point scale from 1 = no, not at all to 7 = yes, very
much. The scale has been shown to have good convergent validity with a validated measure of
depressive reassurance seeking and acceptable internal consistency reliability, with Cronbach’s
alpha of 0.93 (Cougle et al., 2012). In the present study, this measure demonstrated adequate
internal consistency reliability (α = .94).
Health-related Reassurance Seeking. Health-related reassurance seeking behavior was
assessed using the Multidimensional Inventory of Hypochondriacal Traits (MIHT)
hypochondriacal reassurance subscale (Longley, Watson & Noyes, 2005). The MIHT
hypochondriacal reassurance subscale is comprised of eight items that are rated on a five-point
scale. Respondents rate items on a scale from 1 = strongly disagree/definitely false to 5 =
strongly agree/definitely true. The measure has been shown to have good concurrent validity
with other validated measures of hypochondriacal behavior and adequate internal consistency
reliability, with Cronbach’s alpha ranging from 0.82 to 0.86 (Longley, Watson & Noyes, 2005).
In the present study, this subscale demonstrated adequate internal consistency reliability (α =
.89).
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Measures of Social Characteristics
Social Support. Social support was assessed using the 12-item Interpersonal Support
Evaluation List (ISEL-12). The ISEL-12 is comprised of three subscales, appraisal, belonging
and tangible support (Cohen, 2008). Respondents rate items on a four-point scale from 1 =
definitely false, to 4 = definitely true. The scale has demonstrated good concurrent validity with
other validated measures of social support, and adequate internal consistency reliability, with
Cronbach’s alpha ranging from 0.80 to 0.90 (Cohen, 2008). In the present study, this measure
demonstrated adequate internal consistency reliability (α = .93).
Social Constraints. The degree of relationship strain was assessed using the 15-item
Social Constraints Scale (SCS-15). This scale asks about the degree of strain individuals
experience with the most important person in their life (Lepore, Silver, Wortman & Wayment,
1996). Respondents rate items on a four-point scale from 1 = never to 4 = often. This scale has
demonstrated good convergent validity among cancer patients with validated measures of
cancer-related distress, and adequate internal consistency reliability, with Cronbach’s alpha
ranging from 0.85 to 0.95 (Lepore et al., 1996; Lepore & Revenson, 2007). In the present study,
this measure demonstrated adequate internal consistency reliability (α = .94).

Outcome Measure
Fear of Cancer Recurrence. FCR was assessed using the 42-item Fear of Cancer
Recurrence Inventory (FCRI; Simard & Savard, 2009). The FCRI includes the following
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subscales: triggers, severity, psychological distress, coping strategies, functioning impairments,
insight, and reassurance (Simard & Savard, 2009). It has demonstrated good convergent validity
with measures of psychological distress and quality of life, and adequate internal consistency
reliability with Cronbach’s alpha of 0.95 (Simard & Savard, 2009). The severity subscale served
as the main outcome variable, as it is highly related (r = 0.84) to the total FCRI score (Simard &
Savard, 2009). In the present study, the total FCRI scale (α = .92) and the severity subscale (α =
.81) demonstrated adequate internal consistency reliability.

Statistical Analyses
Prior to conducting the main analyses, descriptive statistics were computed for
demographic, clinical and psychological characteristics to characterize the study sample. Log
transformations were computed for those variables demonstrating skewness as defined by
kurtosis less than -1 or greater than 1. However, after performing the main analyses with both
untransformed and log transformed variables and obtaining similar findings with regard to
statistical significance, it was decided to report results using the untransformed variable to retain
the interpretability of results. Sporadic missing data points (n = 33) were addressed using sample
mean imputation.
The first aim was to identify non-modifiable characteristics associated with fear of
recurrence and hypothesis set 1 asserts that greater FCR would be associated with greater
neuroticism, greater conscientiousness, greater perceived risk, younger age and worse disease
severity. To test this hypothesis, Pearson’s r correlations were calculated to determine if there
were significant relationships between FCR as measured by the FCRI, and neuroticism,
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conscientiousness, perceived risk, age and disease severity, as well as gender for which no
hypothesis was offered.
The second aim was to identify modifiable behavioral, cognitive and social modifiable
characteristics associated with FCR. Hypothesis set 2 asserts that greater FCR would be
associated with less self-efficacy for preventing a cancer recurrence, more positive beliefs about
worry, more negative beliefs about worry, more misinterpretation of symptoms, less intolerance
of uncertainty and more rumination (cognitive characteristics). Pearson’s r correlations were
calculated to determine if there were significant relationships between FCR as measured by the
FCRI and self-efficacy, positive beliefs about worry as measured by the MCQ-30 positive beliefs
subscale, negative beliefs about worry as measured by the MCQ-30 negative beliefs about the
danger and uncontrollability of worry subscale, misinterpretation of symptoms as measured by
the MIHT hypochondriacal absorption subscale, and intolerance of uncertainty as measured by
the IUS. Hypothesis set 3 asserts that greater FCR would be associated with more frequent
threat-related and health-related reassurance seeking (behavioral characteristics). Pearson’s r
correlations were calculated to determine if there were significant relationships between FCR as
measured by the FCRI, and threat-related and health-related reassurance seeking behaviors as
measured by the TRSS and MIHT hypochondriacal subscale, respectively. Hypothesis set 4
states that greater FCR would be associated with less social support and greater social constraints
(social characteristics). Pearson’s r correlations were calculated to determine if there were
significant relationships between FCR, as measured by the FCRI and social support, as measured
by the ISEL-12, and social constraints, as measured by the SCS-15.
The third aim was to determine the relative contributions of behavioral, cognitive, and
social characteristics to FCR after accounting for non-modifiable characteristics (i.e.,
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demographic, clinical, and personality characteristics). To achieve this aim, hierarchical multiple
linear regression analyses were conducted. Measures of non-modifiable characteristics that were
found to be significantly correlated with FCR were entered into the analysis on the first step.
Measures of the behavioral, cognitive and social characteristics that were found to be
significantly correlated with FCR were entered into the model simultaneously in a subsequent
step. Change in R2 was used to determine whether or not the modifiable characteristics account
for variance above that accounted for by non-modifiable characteristics. In addition, p-values
were examined to determine which modifiable variables accounted for the most unique variance
in FCR.
A power analysis was conducted using G*Power (Faul, Erdfelder, Lang & Buchner,
2007) to determine the number of participants needed to detect a Pearson’s r = 0.30 (medium
effect size) with a power of 80% and an alpha = .05 (two-tailed). It was determined that a total
sample size of 84 participants would be needed. A second power analysis was conducted to
determine the number of participants needed to obtain power of .80 using multiple linear
regression with an alpha = .05 (two-tailed) to detect an effect size in which two covariates (i.e.,
non-modifiable characteristics) initially account for 5% of the outcome variance, and upwards of
four cognitive, behavioral or social characteristics account for 9% of the remaining variance in
FCR. It was determined that 120 participants would be needed. Therefore, the current study
enrolled and obtained data on 120 participants.
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RESULTS

Participants
Participant flow is shown in Figure 1. One thousand four hundred eighty-six patients
were screened for this study; of these, 1,239 were ineligible based on medical record reviews
(e.g., no colorectal cancer, stage IV or metastatic disease, history of cancer recurrence, history of
other cancer diagnosis) and 49 were unable to be contacted by phone or were not scheduled for a
follow-up appointment. The remaining 198 participants were approached for participation; of
these, 41 refused to participate, and 17 verbally agreed to participate but never signed consent.
One hundred forty patients signed consent (71% of those able to be contacted). Of those who
consented, 13 never completed the study measures and could not be reached, 3 were found to be
ineligible after they consented, and 4 withdrew their consent. Thus, analyses were conducted on
the 120 patients who had evaluable data. Thirty-one percent of participants completed the online
version, while 69% completed the written version of the study questionnaire.
Participant demographic and clinical characteristics are shown in Table 1. Participants
ranged in age from 33 to 94 years (M = 61.28; SD = 12.54). The majority were college-educated
(82%), currently employed (52%), female (51%), married (61%), White (93%) and did not have
minor children (81%). Seventy-seven patients (64%) were diagnosed with rectal cancer and 43
(36%) were diagnosed with colon cancer. On average, participants were 25.45 months (SD =
11.17) from their original cancer diagnosis, 17.46 months (SD = 9.60) from their most recent
cancer treatment, and 2.56 months (SD = 4.13) from their most recent cancer surveillance test.
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Thirty-six participants (30%) had surgery only, 22 (18%) had surgery and chemotherapy, four
(3%) had radiation and chemotherapy, and 58 (48%) had surgery, chemotherapy and radiation.
Four patients (3%) had Lynch Syndrome, an inherited condition associated with increased risk
for colorectal cancer.
Participant scores on the primary outcome, the FCRI severity subscale, ranged from one
to 30 (M = 14.13; SD = 6.50). Using an empirically validated cut-off score of 13, 67 participants
(56%) were identified as meeting criteria for clinically significant FCR (Simard & Savard,
2015).
Participants (n = 120) were compared to non-consenters (n = 58; i.e., those who were
approached but did not provide written consent) on demographic characteristics. Participants
were significantly more likely to be white than non-consenters (p < .05). There were no
significant differences between participants (n = 120) and those who failed to complete measures
(n = 13) on demographic characteristics.

Relationships between Non-Modifiable Characteristics and Fear of Cancer Recurrence
To address Aim 1, Pearson’s r correlations were conducted to determine if FCR was
related to perceived risk, age, disease severity, neuroticism and conscientiousness (see Table 2).
As hypothesized, age, disease severity and neuroticism were associated with FCR in the
expected direction (all p values < .05). That is, younger age, worse disease severity and greater
neuroticism were related to higher levels of FCR. Contrary to hypotheses, perceived risk of
cancer recurrence was not related to FCR. Conscientious was associated with FCR, but not in the
expected direction (p < .05), in that lower levels of conscientiousness were related to greater
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FCR. Additionally, it was found that gender was associated with FCR, such that females reported
greater FCR (p < .01).

Relationships between Modifiable Characteristics and Fear of Cancer Recurrence
To address Aim 2, Pearson’s r correlations were conducted to determine if FCR was
related to modifiable behavioral, cognitive and social characteristics (see Table 3).

Cognitive Characteristics
Consistent with hypothesis set 2, self-efficacy for preventing a cancer recurrence,
positive beliefs about worry, negative beliefs about worry, intolerance of uncertainty and
rumination were related to FCR in the expected direction (all p values < .05). That is, less selfefficacy for preventing a cancer recurrence, more positive beliefs about worry, more negative
beliefs about worry, more intolerance of uncertainty and more rumination were associated with
greater FCR. In contrast, misinterpretation of symptoms was not related to FCR (p = .86).

Behavioral Characteristics
Consistent with hypothesis set 3, threat-related reassurance seeking and health-related
reassurance seeking were related to FCR in the expected direction (p values < .001). That is,
greater threat-related and greater health-related reassurance seeking were related to greater FCR
(p values < .001).
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Social Characteristics
Consistent with hypothesis set 4, social constraints were related to FCR in the expected
direction (p < .01) such that greater social constraints were associated with greater FCR (see
Table 3). However, contrary to expectation, social support was not related to FCR (p = .38).

Non-Modifiable and Modifiable Contributors to Fear of Cancer Recurrence
In order to determine the relative contributions of behavioral, cognitive, and social
characteristics to FCR after accounting for non-modifiable characteristics (i.e., demographic,
clinical, and personality characteristics) hierarchical multiple linear regression analyses were
conducted. Measures of non-modifiable characteristics that were found to be significantly
correlated with FCR were entered into the analysis on the first step (i.e., age, gender, disease
severity, neuroticism and conscientiousness) and measures of the modifiable characteristics that
were found to be significantly correlated with FCR were entered into the model simultaneously
in a subsequent step (i.e., self-efficacy for preventing a cancer recurrence, positive beliefs about
worry, negative beliefs about worry, intolerances of uncertainty, reassurance seeking, healthrelated reassurance seeking and social constraints). Multicollinearity statistics did not indicate
the presence of significant intercorrelations (i.e., VIF > 4, see Table 4). Step one of the
regression analysis that comprised non-modifiable characteristics (i.e., age gender, disease
severity, neuroticism and conscientiousness) was statistically significant (ΔR2 = .33, F(5, 114) =
11.19, p <.001). Addition of modifiable characteristics (i.e., self-efficacy for preventing a cancer
recurrence, positive beliefs about worry, negative beliefs about worry, intolerance of uncertainty,
reassurance seeking, health-related reassurance seeking and social constraints) in step two
significantly increased the amount of variance accounted for by the model beyond what was
accounted for by the non-modifiable characteristics alone (ΔR2 = .13, F(13, 106) = 6.96, p
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<.001). Among the modifiable characteristics, self-efficacy for preventing a cancer recurrence (B
= -.554; p < .05), rumination (B = .157; p < .05), and health-related reassurance seeking (B =
.194; p < .05) significantly accounted for unique variance in FCR, such that less self-efficacy for
preventing a cancer recurrence, greater rumination and greater health-related reassurance seeking
were related to greater FCR.
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Table 1

Participant demographic and clinical characteristics

Characteristic
Age (in years)
Female
White
Non-Hispanic
Married
Years of education
12 or less
13 to 16
17 or more
Current employment
Working
On leave
Not employed
Annual gross income
< $40,000
$40,000-$100,000
>$100,000
Cancer site
Rectal
Colon
Cancer stage at diagnosis
I
II
III
Lynch Syndrome
Time since diagnosis (in months)
Treatment type
Surgery
Surgery + chemotherapy
Radiation + chemotherapy
Surgery + chemotherapy + radiation
Time since most recent treatment (in months)
Time since most recent cancer surveillance (in months)
N = 120
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Mean (SD)/ N (%)
61.28 (12.54)
61 (51)
111 (93)
109 (91)
73 (61)
22 (18)
72 (60)
26 (22)
62 (52)
4 (3)
53 (44)
33 (28)
52 (43)
25 (21)
77 (64)
43 (36)
33 (28)
41 (34)
46 (38)
4 (3)
25.45 (11.17)
36 (30)
22 (18)
4 (3)
58 (48)
17.46 (9.60)
2.56 (4.13)

Table 2
Correlations of non-modifiable characteristics with the Fear of Cancer Recurrence Inventory
Severity Subscale

Non-modifiable characteristics
Perceived risk
Age

FCRI
.12
-.36***

Gender

.26**

Disease severity

.18*

Neuroticism (NEO-FFI-3)

.41***

Conscientiousness (NEO-FFI-3)

-.22*

* p < .05, **p < .01, *** p < .001
Note: FCRI = Fear of Cancer Recurrence Inventory; NEO-FFI-3 = NEO Five-Factor Inventory-3
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Table 3
Correlations of modifiable characteristics with the Fear of Cancer Recurrence Inventory
Severity Subscale

Modifiable characteristics
Cognitive characteristics

FCRI

Self-efficacy

-.41***

Positive beliefs about worry
(MCQ-30)
Negative beliefs about worry
(MCQ-30)
Misinterpretation of symptoms
(MIHT)
Intolerance of uncertainty
(IUS)
Rumination (RRQ)

.22*
.32***
-.02
.30***
.45***

Behavioral characteristics
Reassurance seeking (TRSS)

.34***

Health-related reassurance
seeking (MIHT)

.37***

Social characteristics
Social support (ISEL-12)
Social constraints (SCS)

-.08
.28**

* p < .05, **p < .01, *** p < .001
Note: FCRI = Fear of Cancer Recurrence Inventory; MCQ-30 = Metacognitions Questionnaire;
MIHT = Multidimensional Inventory of Hypochondriacal Traits; IUS = Intolerance of
Uncertainty Scale; RRQ = Rumination-Reflection Questionnaire; TRSS = Threat-related
Reassurance Seeking Scale; ISEL-12 = Interpersonal Support Evaluation List; SCS = Social
Constraints Scale
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Table 4
Two-step hierarchical linear regression
B

Step 1
Gender

SE

β

t (p-value)

5.44

Δ R2 (pvalue)

VIF

.33 (<.001)

.46

1.04

.04

.45 (.66)

1.26

-.16

.04

-.30

-3.77 (<.001)

1.24

Disease severity

.37

.22

.13

1.65 (.10)

1.15

Neuroticism

.16

.08

.21

1.89 (.06)

2.35

-.06

.09

-.06

-.62 (.54)

1.57

Age

Conscientiousness
Step 2

5.05

.13 (<.001)

.39

-.55

.21

-.22

-2.61 (.01)

1.36

Positive beliefs
about worry

.16

.19

.08

.82 (.41)

1.87

Negative beliefs
about worry

-.05

.16

-.03

-.30 (.77)

2.12

Intolerance of
uncertainty

-.09

.05

-.22

-1.84 (.07)

2.82

Rumination

.16

.07

.23

2.37 (.02)

1.87

Reassurance
seeking

.06

.06

.08

.92 (.36)

1.60

Health-related
reassurance
seeking

.19

.08

.20

2.36 (.02)

1.41

-.03

.06

-.05

-.52 (.60)

1.60

Self-efficacy

Social constraints

Mode
l Adj
R2
.30

Note: B = unstandardized regression coefficient; SE = standard error and standard error of the
estimate for step 1 or step 2; β = standardized regression coefficient; VIF = variance inflation
factor
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Assessed for eligibility
(n= 1,486)
Ineligible for participation
(n = 1,239)
Unable to be contacted
(n = 49)

Approached for consent
(n = 198)
Refused to participate
(n = 41)

Verbally agreed, no consent
(n = 17)

Consented
(n = 140)
Ineligible after consent
(n = 3)
Withdrew
(n = 4)

Failed to complete measures
(n = 13)
Completed study measures
(n = 120)
Figure 1
Participant flow chart
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DISCUSSION

The primary purpose of the current study was to identify modifiable characteristics
associated with FCR in order to inform the future creation of an intervention for cancer survivors
experiencing FCR. This was accomplished by first examining non-modifiable and modifiable
characteristics associated with FCR and then evaluating the relative contributions of modifiable
and non-modifiable characteristics to FCR.
Consistent with prior research findings (Simard et al., 2013, McGinty et al., 2012; Savard
& Ivers, 2013; Crist & Grunfeld, 2013; Koch, Jansen, Brenner & Arndt, 2013; Lahey, 2009), this
study found significant relationships between non-modifiable characteristics (i.e., demographic,
clinical and personality characteristics) and FCR, such that patients who were younger, female,
had worse disease severity and reported greater neuroticism, reported greater FCR. Contrary to
expectations and prior research findings (McGinty et al., 2012), perceived risk was not
associated with FCR. Conscientiousness was related to FCR, but not in the direction
hypothesized. That is, the current study found that those who reported lower conscientiousness,
reported greater fear of cancer recurrence. This last finding is consistent with a recent study
among Chinese cancer survivors, which also demonstrated an inverse relationship between
conscientiousness and FCR (Liao, Yeung, Wong, Warmoth & Lu, 2017). This study also
reported that the relationship was mediated by a greater sense of hopelessness. Consistent with
this idea, research suggests that those low on conscientiousness tend to report a lower internal
locus of control and are less likely to engage in health behaviors (Christensen, Moran, & Wiebe,
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1999; Molloy, O’Carroll & Ferguson, 2014). Taken together, these findings suggest that those
low in conscientiousness may perceive that they have limited ability to influence a cancer
recurrence and, therefore, experience greater FCR.
Consistent with hypotheses regarding modifiable characteristics, the current study found
that cognitive, behavioral and social characteristics were associated with FCR. In regards to
cognitive characteristics, self-efficacy for preventing a cancer recurrence, positive beliefs about
worry, negative beliefs about worry, intolerance of uncertainty and rumination were related to
FCR in the expected direction. That is, survivors who reported heightened FCR, tended to feel
less confident in their ability to prevent a cancer recurrence, tended to view worry as beneficial
yet also more dangerous and uncontrollable, tended to be less tolerant of uncertainty and tended
to report more rumination. Similarly, a recent study by Butow and colleagues (2015) examining
relationships between metacognitions and FCR found that among breast and prostate cancer
survivors, those with greater FCR had more positive beliefs about worry (e.g., worrying helps me
cope) and more negative beliefs about worry (e.g., my worrying is dangerous for me). In
addition, findings are consistent with a study by McGinty et al. (2016) which showed that lower
coping self-efficacy was associated with heightened FCR among breast cancer survivors. Among
novel findings from the current study are results showing that survivors who tend to be less
tolerant of uncertainty and engage in more rumination reported greater FCR. These finding are
consistent with the literature on psychological distress in cancer survivors which has shown that
survivors reporting greater distress tend to be less tolerant of uncertainty (Eisenberg et al., 2014;
Kurita, Garon, Stanton & Meyerowitz, 2013) and tend to report greater rumination (Galfin &
Watkins, 2012; Hill & Watkins, 2017). Contrary to hypotheses and prior research (Mehnert,
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Berg, Henrich & Herschbach, 2009; Lee-Jones, Humphris, Dixon & Hatcher, 1997),
misinterpretation of symptoms was not related to FCR in the current study.
Results from the current study demonstrated that behavioral characteristics, including
threat-related and health-related reassurance seeking were associated with FCR. That is, greater
threat-related and health-related reassurance seeking were related to greater FCR. These findings
are consistent with prior research on health anxiety, which emphasizes the importance of
reassurance seeking in maintaining health anxiety (Furer, Walker & Freeston, 2001; Langlois &
Ladouceur, 2004). Prior research on FCR suggests that those with greater FCR visit the doctor
more often (Lebel, 2013; Koch, 2014) and engage in more reassurance seeking behaviors
(McGinty, Small, Laronga & Jacobsen, 2016). Also consistent with study findings, intervention
studies targeting reassurance seeking behaviors have demonstrated reductions in FCR (Lebel et
al., 2014). However, this is the first study to differentiate between threat-related and healthrelated reassurance seeking.
With regard to social characteristics, greater social constraint was associated with greater
FCR in the current study. Although no study to date has examined the relationship between
social constraints and FCR, this is consistent with prior research demonstrating the detrimental
impact of social constraints on emotional adjustment among cancer survivors (Lepore, 2001;
Lepore & Revenson, 2007) and a recent study which found that social isolation was related to
FCR (Koch-Gallenkamp, Bertram, Eberle, Holleczek & Schmid-Hopfner et al., 2016). Contrary
to expectation, social support was not associated with FCR. Prior research findings on this topic
are mixed (Crist & Grunfeld, 2013; Thewes, Bell, Butow, Beith, & Boyle et al., 2013). Taken
together, findings from this study suggest that perceptions of strained interpersonal relationships
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with important others (i.e., social constraints), rather than lack of social support, contributes to
greater FCR.
Findings from multivariate analyses indicated that modifiable characteristics (i.e.,
positive beliefs about worry, negative beliefs about worry, intolerances of uncertainty, threatrelated reassurance seeking, health-related reassurance seeking and social constraints) accounted
for approximately 13% of the variance in FCR after controlling for non-modifiable
characteristics (i.e., age, gender, disease severity, neuroticism and conscientiousness). Among
the modifiable characteristics in the model, self-efficacy for preventing a cancer recurrence,
rumination and health-related reassurance seeking accounted for unique variance in FCR, such
that less self-efficacy for preventing a cancer recurrence, greater rumination and greater healthrelated reassurance seeking were related to greater FCR. These findings are consistent with
cognitive behavioral models of health anxiety which emphasize the role that reassurance seeking
behaviors and cognitive processes, such as rumination, play in maintaining health anxiety (Furer,
Walker & Freeston, 2001; Langlois & Ladouceur, 2004; Norris & Marcus, 2014). These findings
also lend support to a cognitive processing model of FCR recently proposed by Fardell et al.
(2016). This model identifies problematic styles of information processing, such as rumination,
as contributors to heightened FCR, and proposes a bidirectional relationship between heightened
FCR and emotional, behavioral (e.g., reassurance seeking) and cognitive responses to cancer.
Other key components of the Fardell model, which are supported by findings from the current
study, include the crucial role that metacognitions or unhelpful beliefs about worry play in the
development and maintenance of FCR (Fardell et al., 2016).
The current study has several strengths. First, it evaluated a theoretical model of
clinically relevant modifiable contributors to FCR comprised of cognitive, behavioral and social
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characteristics. Second, this study included both males and females, allowing us to examine
gender as a potential non-modifiable characteristic impacting FCR and making its findings
generalizable to both genders. Third, it addressed the general lack of prior research on predictors
of FCR among colorectal cancer survivors, which is among the most common cancers in U.S.
adults.
In addition, several study limitations should be considered. First, this study used a crosssectional design. This feature does not allow causal conclusions to be drawn about relationships
between FCR and modifiable characteristics. Studies using longitudinal research designs should
be conducted to examine the temporal direction of these relationships and consider potential
bidirectional relationships between FCR and cognitive, behavioral and social characteristics in
order to deepen our conceptual understanding of FCR. Second, due to the homogeneity of race
and ethnicity in the sample, findings may not generalize to populations of cancer patients with
more diverse backgrounds. Accordingly, future studies should recruit more heterogeneous
samples of cancer patients. Third, although the participation rate for this study was relatively
high (71% of those able to be contacted), it is possible that our sample is not representative of the
colorectal cancer population. For example, it could be that those with higher levels of FCR chose
not to participate due to discomfort with questions or their preference to avoid thinking about the
potential for a recurrence.
Findings from the present study have numerous implications for clinical practice. First,
given that approximately 56% of colorectal cancer survivors in the current study met criteria for
clinically significant FCR, these results suggest that FCR is relatively common among colorectal
cancer survivors. Therefore, oncologists and mental health professionals treating colorectal
cancer patients should consider screening for FCR in their patients. Second, these findings can
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assist clinicians in identifying those patients who might be most in need of an intervention
designed to address FCR. Results of the current study suggest that this is a particularly relevant
discussion for those patients who are younger, female, have poorer disease prognosis, report
greater neuroticism and report lower conscientiousness. Third, the findings regarding modifiable
characteristics have implications for intervention development. Specifically, they suggest that
interventions to address FCR should target self-efficacy for preventing a cancer recurrence,
rumination and health-related reassurance seeking.
Although no intervention studies have examined self-efficacy for preventing a cancer
recurrence as a mediator, motivational interviewing and social-cognitive interventions have
demonstrated positive effects on behavior change via self-efficacy in other populations. For
example, one study examining the efficacy of a brief motivational interview on drinking
behaviors found that the relationship between the intervention and heavy drinking was mediated
by increases in self efficacy (Magill et al., 2017). Another randomized controlled trial evaluating
a social-cognitive intervention for fruit and vegetable consumption identified self-efficacy as a
mediator for facilitating dietary changes (Kreausukon, Gellert, Lippke & Schwarzer, 2012).
Future studies should examine the effects of motivational interviewing and social-cognitive
interventions for influencing FCR via self-efficacy.
Cognitive behavioral therapy (CBT), metacognitive therapy (MCT) and mindfulnessbased approaches have all shown efficacy for targeting rumination in other populations. For
example, in randomized controlled trials assessing the efficacy of CBT among depressed
patients, rumination has been shown to mediate improvements in depressive symptoms
(Teismann, von Brachel, Hanning, Grillenberger, & Hebermehl, et al., 2014; Watkins, Mullan,
Wingrove, Rimes & Steiner et al., 2011). Although MCT is a relatively novel treatment

39

approach, a recent meta-analysis showed that MCT is effective in reducing rumination, anxiety
and depression. (Normann, van Emmerik & Morina, 2014). Similarly, randomized controlled
trials evaluating mindfulness-based interventions among other populations (i.e., lung, cervical
and breast cancer survivors, depressed patients) have demonstrated beneficial effects on
psychological distress through the mechanism of rumination (Boyle, Stanton, Ganz, Crespi &
Bower, 2017; Schellekens, van den Hurk, Prins, Donders, Molema et al., 2017; Shahar, Britton,
Sbarra, Figueredo & Bootzin, 2010; Shao, Gao & Cao, 2016). It is quite possible that these
findings may extend to FCR.
Behavioral therapy and cognitive-existential therapy have shown efficacy for targeting
reassurance seeking behaviors. A study conducted by Weck and colleagues (2014) which
compared the effectiveness of cognitive therapy and exposure therapy in treating health anxiety,
found that those who underwent exposure therapy were significantly less likely to engage in
safety behaviors (i.e., reassurance seeking, body checking). A similar randomized controlled trial
of behavioral therapy (applied relaxation versus worry exposure) in GAD patients, demonstrated
beneficial treatment effects via reductions in reassurance seeking behaviors (Beesdo-Baum,
Jenjahn, Hofler, Leuken, Becker & Hoyer, 2012).
In conclusion, the current study adds to the literature on FCR by identifying nonmodifiable and modifiable factors related to FCR and distinguishing those modifiable factors
which uniquely explain variance in FCR. Specifically, this study found that when accounting for
non-modifiable factors (i.e., age, gender, disease severity, neuroticism and conscientiousness),
modifiable factors (i.e., self-efficacy, positive beliefs about worry, negative beliefs about worry,
intolerance of uncertainty, rumination, reassurance seeking, health-related reassurance seeking
and social constraints) significantly contribute to variance in FCR, with self-efficacy, health-
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related reassurance seeking and rumination contributing unique variance. These findings provide
support for a cognitive behavioral model of FCR and suggest that FCR interventions target selfefficacy, health-related reassurance seeking and rumination.
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